Portland, OR -- (SBWire) -- 07/28/2017 --Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. The global Alzheimers disease market has observed tremendous growth in the recent years, owing to the high prevalence of Alzheimers disease and increased life expectancy of population. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Presently, very few therapeutic alternatives are available in the market and none of them provide a complete cure for this condition. This indicates an impending market need that would provide lucrative growth opportunities to the industry players.

Get full summary of the Report:https://www.alliedmarketresearch.com/alzheimer-disease-therapeutics-and-diagnostics-market

The research collaborations and new product launches are some of the key strategies adopted by leading industry players. For instance, Actavis plc in collaboration with Adamas Pharmaceuticals Inc. recently announced the US FDA approval of Namzaric, a fixed-dose combination of memantine and donepezil. The drug is expected to be launched in the first half of year 2015. Further, in Jan 2015, Johnson & Johnson signed a research deal with a Swiss biotech firm AC Immune, to develop anti-tau Alzheimer's vaccines.

The companies profiled in this report include, Pfizer, Inc., Eisai Co., Ltd., Novartis AG, H. Lundbeck A/S, Forest Laboratories, Inc., TauRx Therapeutics Ltd, AC Immun, and Johnson & Johnson.

Get Sample of Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1441

KEY MARKET SEGMENTS:

The Alzheimers Disease Therapeutics and Diagnostics Market is segmented below:

Alzheimers Disease Therapeutics and Diagnostics Market By Therapeutics

-Marketed Drugs
-Cholinesterase inhibitors
-NMDA receptor antagonist
-Pipeline Drugs

Alzheimers Disease Therapeutic and Diagnostic Market By Diagnostics

-Lumbar puncture test
-Computed tomography (CT) scan
-Magnetic resonance imaging (MRI)
-Electroencephalography (EEG)
-Positron emission tomography (PET) scan
-Others

Alzheimers Disease Therapeutics and Diagnostics Market By Geography

-North America
-Europe
-Asia-Pacific
-LAMEA